Stemness kinase

Stemness kinase Products

  • All (2)
  • Stemness kinase Inhibitor (1)
  • New Stemness kinase Products
Catalog No. Product Name Information Product Use Citations Product Validations
S8572 Amcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
EMBO J, 2025, 44(13):3645-3668
Cell Rep, 2022, 38(7):110390
Sci Rep, 2022, 12(1):7
F1339New LIN28A Antibody [A20G22] LIN28A
S8572 Amcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
EMBO J, 2025, 44(13):3645-3668
Cell Rep, 2022, 38(7):110390
Sci Rep, 2022, 12(1):7
F1339New LIN28A Antibody [A20G22] LIN28A

Choose Selective Stemness kinase Inhibitors